Skip to main content
. Author manuscript; available in PMC: 2024 Mar 28.
Published in final edited form as: J Natl Compr Canc Netw. 2022 Oct;20(10):1134–1138. doi: 10.6004/jnccn.2022.7048

Table 1.

Type and grade of immune-related adverse events experienced by patients who received SARS-CoV-2 mRNA vaccine and immune checkpoint inhibitor therapy within 90 days

Grade 1 Grade 2 Grade 3

Arthralgias 3 - -
Arthritis plus rash 1 1 -
Colitis - - 1
Dermatitis 10 - -
Diarrhea 2 - 3
Pneumonitis 2 1 -
Thyroiditis 1 - -
Transaminitis 2 - -

Total 21 2 4